JJ Sheehan | Business Development Manager
Novel Bio

Matthew Weinstock, PhD, is Chief Technology Officer of Novel Biotechnology, where he leads the development and scaling of the company's plasmid DNA production operations, encompassing molecular cloning, strain engineering, upstream and downstream process development, analytical testing, facilities, supply chain, and program management. Trained as a biochemist at the University of Utah School of Medicine, he has more than a decade of experience building and leading advanced drug discovery and biomanufacturing organizations. Across these roles, he has consistently translated complex scientific capabilities into rigorously operationalized, commercially deployed platforms supporting programs with emerging biotechnology innovators, government agencies including DARPA, and top-10 pharmaceutical partners.